Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Changing the environment around stem cells could help tissue repair, but it's hard to be precise and avoid side effects.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Pegvaliase is recommended for treating adults with phenylketonuria.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Microneedles offer a promising, painless way to treat skin diseases but need improvements for better use.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.